Metlife Inc (MET) Stock Price & Analysis

Metlife Inc (MET) rose 2.47% to USD 94.83 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.

MET last closed at USD 92.54; the session ranged USD 91.34–94.84 on volume of 3,737,103 shares. Market capitalization is $61.02B, with a 52-week range of USD 67.33–94.86 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.

Key Statistics (as of July 25, 2026 at 01:12 UTC)

PriceUSD 94.83
Change▲ 2.47% (up)
Previous CloseUSD 92.54
OpenUSD 92.16
Day RangeUSD 91.34 – 94.84
52-Week RangeUSD 67.33 – 94.86
Volume3,737,103 shares
Market Cap$61.02B
ExchangeNYQ

Technical Analysis (MET)

Nexqual's technical model rates MET "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.

Overall SignalBUY
RSI (14)67.05 (neutral)
vs SMA50Above (USD 86.8)
MACD2.18 (positive)

Analyst Ratings (MET)

Wall Street analysts rate MET "Buy" based on 16 analysts, with a mean price target of USD 97.75 (range USD 75–106), per Nexqual as of July 25, 2026 at 01:12 UTC.

Consensus RatingBuy
Analyst Count16
Mean TargetUSD 97.75
High TargetUSD 106
Low TargetUSD 75
Buy / Hold / Sell12 / 5 / 1

Earnings (MET)

Next Earnings Date2026-08-05
EPS EstimateUSD 2.29
Revenue Estimate$19.55B

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 2.42 vs est 2.27 ▲ beat
2025-12-31USD 2.49 vs est 2.34 ▲ beat
2025-09-30USD 2.37 vs est 2.32 ▲ beat
2025-06-30USD 2.02 vs est 2.16 ▼ miss

Source: Nexqual, July 25, 2026 at 01:12 UTC.

Financials & Fundamentals (MET)

Total Revenue$77.58B
Revenue Growth (YoY)+2.70%
Gross Margin+23.75%
Operating Margin+9.92%
Profit Margin+4.67%
ROE+13.01%
Debt / Equity178.02
Current Ratio2.09
Total Cash$27.63B
Total Debt$49.49B
Free Cash Flow$-17.43B

Source: Nexqual, July 25, 2026 at 01:12 UTC.

Financial Health Score (MET)

Nexqual rates Metlife Inc's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:12 UTC.

GrowthSolid — Revenue +8% YoY (annual)
ProfitabilityMixed — Gross margin 24%, operating 10%
Balance SheetWeak — $27.6B cash vs $49.5B debt
Cash FlowWeak — FCF negative: -$17.4B, burning cash
EfficiencyMixed — ROE 13%, ROA 0.5%

Ownership (MET)

Insider Ownership+16.42%
Institutional Ownership+78.48%
Shares Outstanding643.44M
Float537.49M
Short % of Float+2.23%

Source: Nexqual, July 25, 2026 at 01:12 UTC.

Leadership (MET)

Metlife Inc is led by Michel Abbas Khalaf, CEO, President & Director, per Nexqual as of July 25, 2026 at 01:12 UTC.

CEO, President & DirectorMichel Abbas Khalaf
Executive VP, CFO & Head of Investment ManagementJohn Dennis McCallion (age 51)
Regional President of U.S. Business & Head of MetLife HoldingsRamy Tadros (age 49)
Executive VP & Chief Marketing OfficerMichael Roberts

Major Backers & Investors (MET)

Notable institutional backers of Metlife Inc include Dodge & Cox Inc., Price (T.Rowe) Associates Inc, Pzena Investment Management LLC, according to Nexqual as of July 25, 2026 at 01:12 UTC.

Active Investors

InvestorStake
Dodge & Cox Inc.13.78%
Price (T.Rowe) Associates Inc3.54%
Pzena Investment Management LLC1.76%
Morgan Stanley1.73%
Fidelity1.09%

Index Funds (Passive)

FundStake
Vanguard Group18.59%
BlackRock9.12%
State Street4.94%
Geode Capital2.06%
Dimensional Fund Advisors1.11%

Source: Nexqual, July 25, 2026 at 01:12 UTC.

From Metlife Inc's Latest SEC 10-K Filing (filed 2026-02-19)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
PRUPrudential Financial, Inc.USD 119.96▲ 0.93%
HIGThe Hartford Insurance Group, IUSD 140.53▼ 0.22%
ALLAllstate Corporation (The)USD 259.97▲ 3.23%
LNCLincoln National CorporationUSD 41.36▼ 0.82%
AFLAFLAC IncorporatedUSD 125.6▲ 1.63%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.